Your doctor may suggest treatment with glucocorticoids (such as prednisone) which are given along with other medicines that slow down the immune response.
Medicines used to treat GPA include:
Bisphosphonate (Fosamax) to prevent bone loss caused by prednisone
Folic acid or folinic acid (leucovorin) -- if you are taking methotrexate
Trimethoprim/sulfamethoxazole to prevent lung infections
Support groups with others who suffer from similar diseases may help patients and their families learn about their diseases and adjust to the changes associated with the treatment.
Without treatment, people with this disease can die within a few months.
With treatment, the outlook for most patients is good. Studies have shown that most people who receive corticosteroids and cyclophosphamide get much better.
The disease may return in about half of all patients. In these cases, the disease often comes back within 2 years of stopping treatment.
Complications most often occur when the disease is not treated. People with GPA develop tissue damage (lesions) in the respiratory tract and the kidneys. Kidney lesions cause glomerulonephritis, which may result in blood in the urine and kidney failure. Kidney disease can quickly get worse. Kidney function may not improve even when the condition is controlled by medicines.
If untreated, kidney failure and death occur in most of patients.
Other complications may include:
Coughing up blood
Nasal septum perforation (hole inside the nose)
Side effects from medicines used to treat the disease
When to Contact a Medical Professional
Call your health care provider if you develop chest pain, coughing up blood, blood in the urine, or other symptoms of this disorder.
There is no known prevention.
Collard HR, King TE, Schwartz MI. Diffuse Alveolar Hemorrhage and Rare Infiltrative Disorders of the Lung. In: Mason RJ, Broaddus VC, Martin TR, et al. Murray & Nadel's Textbook of Respiratory Medicine. 5th ed. Philadelphia, Pa: Saunders Elsevier; 2010:chap 60.
Savage COS, Harper L. Antineutrophil Cytoplasm Antibody–Associated Vasculitis. In: Firestein GS, Budd RC, Gabriel SE, et al, eds. Kelley's Textbook of Rheumatology. 9th ed. Philadelphia, Pa: Saunders Elsevier; 2012:chap 89.
Falk RJ, Gross WL, Guillevin L, et al. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Ann Rheum Dis. 2011;70(4):704.
Allen J. Blaivas, DO, Clinical Assistant Professor of Medicine UMDNJ-NJMS, Attending Physician in the Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Veteran Affairs, VA New Jersey Health Care System, East Orange, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by A.D.A.M. Health Solutions, Ebix, Inc., Editorial Team: David Zieve, MD, MHA, Bethanne Black, Stephanie Slon, and Nissi Wang.